Oxra-L (Dapagliflozin/Linagliptin)

Oxra-L combines Dapagliflozin and Linagliptin to manage type 2 diabetes with improved blood sugar control and minimal side effects.

pack size Price Add to Cart
60 Tablets - USD $0.88 Per Tablet$53.00
View Cart
120 Tablets - USD $0.78 Per Tablet$94.00
View Cart
240 Tablets - USD $0.68 Per Tablet$164.00
View Cart

Oxra-L (Dapagliflozin/Linagliptin)

Active IngredientDapagliflozin/Linagliptin
Indication:Type 2 diabetes
Manufacturer:Sun Pharmaceutical Industries Ltd
Strength10mg/5mg
Packaging10 Tablets in 1 Strip

Oxra-L is a combination medication containing Dapagliflozin and Linagliptin, designed for the effective management of type 2 diabetes mellitus. Dapagliflozin is an SGLT2 inhibitor that helps lower blood sugar by removing excess glucose through urine, while Linagliptin is a DPP-4 inhibitor that boosts insulin secretion and reduces sugar production in the liver. Together, they offer a dual-action approach to blood sugar control, especially helpful for patients who do not achieve adequate control with single-drug therapy.

Oxra-L is taken once daily and can be used alone or alongside other diabetes treatments. It is generally well tolerated, with a low risk of hypoglycemia when not combined with insulin or sulfonylureas. For best results, use it as part of a broader diabetes management plan that includes diet, exercise, and regular blood glucose monitoring.

pack size

60 Tablets – USD $0.88 Per Tablet, 120 Tablets – USD $0.78 Per Tablet, 240 Tablets – USD $0.68 Per Tablet

There are no reviews yet.

Be the first to review “Oxra-L (Dapagliflozin/Linagliptin)”